Dipeptidyl‐peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon‐like peptide‐1(7–36)amide, peptide histidine methionine and is responsible for their degradation in human serum

European Journal of Biochemistry

Volumn 214, Issue 3, 1993, Pages 829-835

  MENTLEIN, Rolf ^a   GALLWITZ, Baptist ^b   SCHMIDT, Wolfgang E ^b  

^a Anatomisches Institut   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE;

ARTICLE; HUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SERUM;

AMINO ACID SEQUENCE; ANTIGENS, CD26; DIPEPTIDYL PEPTIDASES; GASTRIC INHIBITORY POLYPEPTIDE; HUMAN; MALE; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PEPTIDE PHI; SUBSTRATE SPECIFICITY; SUPPORT, NON-U.S. GOV'T;

EID: 0027215348     PISSN: 00142956     EISSN: 14321033     Source Type: Journal    
DOI: 10.1111/j.1432-1033.1993.tb17986.x     Document Type: Article

References (33)

1. Dipeptidyl(amino)peptidase IV and aminopeptidase M metabolize circulating substance P in vivo
2. Gastrointestinal hormones and carcinoid tumors and syndrome
3. Kinetics of dipeptidyl peptidase IV proteolysis of growth hormone‐releasing factor and analogs
4. Catabolism of rat growth hormone‐releasing factor(1–29)amide in rat serum and liver
5. Analysis of the degradation of insulinotropin [GLP‐1(7–37)] in human plasma and production of degradation resistant analogs
6. The VIP/PHI/secretin/helodermin/helospectin/GRF family: structure‐function relationship of the natural peptides, their precursors and synthetic analogues as tested in vitro on receptors and adenylate cyclase in a panel of tissue membranes
7. Dipeptidyl peptidase IV and trypsin‐like enzymatic degradation of human growth hormone‐releasing hormone in plasma
8. Glucagon‐like peptide‐1 (7–36)amide: characterization of the domain responsible for binding to its receptor on rat insulinoma RINm5F cells
9. Zur Lokalisation der Dipeptidylpeptidase IV (DPP IV). Histochemische und biochemische Untersuchungen
10. Dipeptidyl peptidase IV in rat organs. Comparison of immunohistochemistry and activity histochemistry
11. Mechanism of proline‐specific proteinases: (I) substrate specificity of dipeptidyl peptidase IV from pig kidney and proline‐specific endopeptidase from Flavobacterium meningosepticum
12. Liver dipeptidyl peptidase IV hydrolyzes substance P
13. Amino acid sequence and heterogeneity of gastric inhibitory polypeptide (GIP)
14. 2 in bovine and porcine plasma
15. Studies on dipeptidyl(amino)peptidase IV. II. Blood vessels
16. Identification of the bile canicular cell surface molecule GP110 as the ectopeptidase dipeptidyl peptidase IV: an analysis by tissue distribution, purification and N‐terminal amino acid sequence
17. Proline residues in the maturation and degradation of peptide hormones and neuropeptides
18. Dipeptidyl peptidase IV as a new surface marker for a subpopulation of human T‐lymphocytes
19. Purification of two dipeptidyl aminopeptidases II from rat brain and their action on prolinecontaining neuropeptides
20. Substance P in human plasma is degraded by dipeptidyl peptidase IV, not by cholinesterase
21. The degradation of bioactive peptides and proteins by dipeptidyl peptidase IV from human placenta
22. Isolation and characterization of dipeptidyl peptidase IV from human placenta
23. Are diprotin A (Ile‐Pro‐Ile) and diprotin B (Val‐Pro‐Leu) inhibitors or substrates for dipeptidyl peptidase IV?
24. Extended investigation of the substrate specificity of dipeptidyl peptidase IV from pig kidney
25. Heterogeneity of VIP receptors
26. Structural requirements for the occupancy of pituitary adenylate‐cyclase‐activating peptide (PACAP) receptors and adenylate cyclase activation in human neuroblastoma NB‐OK‐1 cell membranes
27. Commercially available preparations of porcine glucose‐dependent insulinotropic polypeptide (GIP) contain a biologically inactive GIP‐fragment and cholecystokinin‐33/‐39
28. N‐terminal tyrosine‐alanine is required for the insulin‐releasing activity of glucose‐ dependent insulinotropic polypeptide (GIP)
29. Complete high‐performance liquid chromatographic separation of 4‐N,N‐dimethylamino‐azobenzene‐4′‐thiohydantoin and 4‐dimethylaminoazobenzene‐4′‐sulphonyl chloride amino acids using the same reverse‐phase column at room temperature
30. Glucagon antagonists: contribution to binding and activity of the amino‐terminal sequence 1–5, position 12, and the putative α‐helical segment 19–27
31. Statistical estimations in enzyme kinetics
32. Manual microsequence determination of proteins and peptides with the DABITIC/PITC method